Showing results for "THE PROMISE" in Computers & Technology

When it comes to tech, the mainstream headlines are bleak. While legitimate concerns drive these fears, we need to equally account for the fact that tech affords young people something incredibly valuable—a rare space for self-actualization. In From Pessimism to Promise, award-winning author Payal Arora explains that, outside the West, where most of the world's youth reside, there is a significant different outlook on tech: in fact, there is a contagion of optimism toward all things digital.

What does it mean to call something "new"? Why is Western art and culture, even after postmodernism, still so obsessed with the concept? What are the consequences of relying on culture to bring about social change? In this provocative book, David Balzer argues that Western culture was never designed to produce truly new or original artifacts. Rather, we move from fixation to fixation, trend to trend—a cycle of creation and destruction with deep origins in Judeo-Christianity and the paganism that preceded it.

Bob Muglia helps us understand how innovation in data and information technology have led us to AI—and how this technology must shape our future. The long-time Microsoft executive, former CEO of Snowflake, and current tech investor maps the evolution of the modern data stack and how it has helped build today's economy and society. And he explains how humanity must create a new social contract for the artificial general intelligence (AGI)—autonomous machines intelligent as people-that he expects to arrive in less than a decade.

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.